GKIM
RCKT icon

GW&K Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

GW&K Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-74,734
Closed -$1.82M – 237
2016
Q4 		$1.82M Sell
74,734
-13,803
-16% -$394K 0.04% 211
2016
Q3 		$3.36M Sell
88,537
-2,402
-3% -$75.5K 0.06% 195
2016
Q2 		$2.71M Buy
90,939
+10,749
+13% +$378K 0.06% 198
2016
Q1 		$2.37M Buy
80,190
+38,089
+90% +$1.14M 0.05% 200
2015
Q4 		$1.91M Buy
42,101
+5,440
+15% +$237K 0.04% 191
2015
Q3 		$1.38M Buy
+36,661
New +$1.68M 0.03% 195

Other funds holding RCKT

RCP
Rho Capital Partners New York $20.4M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FO
FT Options Chicago, Illinois $66.4M AUM 18.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GW&K Investment Management's RCKT Position: Q1 2017 in Review

GW&K Investment Management sold out of Rocket Pharmaceuticals (RCKT) in Q1 2017, closing a stake of 74,734 shares — an estimated $1.82M sold.

GW&K Investment Management first reported a position in RCKT in Q3 2015 and held it in 6 quarters. The position peaked at $3.36M in Q3 2016. 67 funds tracked by Wall St. Rank hold RCKT as of Q1 2017.

  • GW&K Investment Management reported no remaining Rocket Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • GW&K Investment Management sold 74,734 Rocket Pharmaceuticals shares in Q1 2017, an estimated $1.82M.
  • GW&K Investment Management first reported a position in Rocket Pharmaceuticals in Q3 2015 and held it in 6 quarters.
  • GW&K Investment Management's Rocket Pharmaceuticals position peaked at $3.36M in Q3 2016.
  • 67 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2017.

Based on GW&K Investment Management's 13F filing for Q1 2017, filed 10 Apr 2017.